As antibiotics fail, global consumption of antibiotics skyrockets, further driving drug resistance

March 26, 2018, The Center for Disease Dynamics, Economics & Policy
Credit: CC0 Public Domain

Despite the threat of a global health crisis in antibiotic resistance, worldwide use of antibiotics in humans soared 39 percent between 2000 and 2015, fueled by dramatic increases in low-income and middle-income countries (LMICs), according to a new study in the Proceedings of the National Academy of Sciences (PNAS). The study, which analyzed human antibiotic consumption in 76 countries, is the most comprehensive assessment of global trends to date.

Researchers from the Center for Disease Dynamics, Economics & Policy (CDDEP), Princeton University, ETH Zurich and the University of Antwerp conducted the study, which found that antibiotic consumption rates increased worldwide from 11.3 to 15.7 defined daily doses (DDDs) per 1,000 inhabitants per day between 2000 and 2015. DDDs are a statistical and standardized measure of and represent the assumed average maintenance dose per day for a drug used for its main indication in adults.

Antibiotic resistance is a global health problem; when it emerges in one place, it quickly spreads to other parts of the world. The study underscores the need for consistent global surveillance of and policies to curtail unnecessary antibiotic use.

Loss of effective is driven in large part by antibiotic consumption, most of which is inappropriate and does nothing to improve health. However, while reducing antibiotic use is critical, increasing access to antibiotics in lower-income countries is also necessary, as these countries suffer from the highest rates of illness and death caused by infectious disease, the study researchers pointed out.

"Finding workable solutions is essential, and we now have key data needed to inform those solutions," said CDDEP researcher and study co-author Eili Klein. "Now, more than ever, we need effective interventions, including stewardship, public education, and curbing overuse of last-resort antibiotics."

Major findings from the PNAS study are as follows:

  • Total global use of antibiotics in humans was estimated to be 35 billion DDDs in 2015, a 65 percent increase from 2000, while the consumption rate increased 39 percent, from 11.3 to 15.7 DDDs per 1,000 inhabitants per day.
  • Antibiotic use in LMICs increased 114 percent in total and 77 percent per 1,000 inhabitants per day between 2000 and 2015 (some of total use increase was due to population growth). Some LMICs had rates of consumption that surpassed those of high-income countries. However, many LMICs still have considerably lower per capita consumption rates than high-income countries, due to access issues such as the high cost of drugs and patent protections.
  • The consumption rate of broad-spectrum penicillins, the most commonly consumed class of antibiotics, increased 36 percent between 2000 and 2015 globally. The greatest increase was in LMICs, where the rate of antibiotic consumption increased 56 percent, compared to 15 percent in high-income countries.
  • Consumption of new and last-resort antibiotic classes, such as linezolid, carbapenems, and colistin, increased significantly in nearly all countries. The United States remained one of the largest consumers of glycylcyclines (tigecycline) and oxazolidinones (linezolid), although use of these newer drugs in other countries use has surpassed that of the US in recent years.
  • Consumption increases in LMICs were driven largely by economic growth—a pattern not seen in high-income countries.

Despite the rising rates of antibiotic use worldwide, the results suggest that reducing antibiotic consumption is possible. Consumption in high-income countries actually fell slightly over the study period. In addition, the considerable variation in per capita use across suggests that there are lessons to be learned.

CDDEP Director and study co-author Ramanan Laxminarayan noted that more than a year has passed since the United Nations General Assembly recognized the global threat of antibiotic resistance, yet little action has been taken since then.

"We must act decisively and we must act now, in a comprehensive manner, to preserve antibiotic effectiveness," Laxminarayan said. "That includes solutions that reduce consumption, such as vaccines or infrastructure improvements, particularly in low-income and . New drugs can do little to solve the resistance problem if these drugs are then used inappropriately, once they are introduced."

Explore further: Antibiotics often inappropriately prescribed for hospitalized kids, global study suggests

More information: Eili Y. Klein el al., "Global increase and geographic convergence in antibiotic consumption between 2000 and 2015," PNAS (2018). www.pnas.org/cgi/doi/10.1073/pnas.1717295115

Related Stories

Antibiotics often inappropriately prescribed for hospitalized kids, global study suggests

March 22, 2018
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal ...

High levels of antibiotic-resistance in Indian poultry farming raises concerns

July 20, 2017
A new study from India raises questions about the dangers to human health of farming chicken with growth-promoting antibiotics—including some of the same drugs used in raising millions of chickens in the United States and ...

EU report: More evidence on link between antibiotic use and antibiotic resistance

July 27, 2017
The European Food Safety Authority, the European Medicines Agency and the European Centre for Disease Prevention and Control are concerned about the impact of use of antibiotics on the increase in antibiotic-resistant bacteria. ...

GI surgical site infections higher in low-income countries

February 14, 2018
(HealthDay)—The burden of surgical site infection (SSI) after gastrointestinal surgery is greater for countries with low income as classified by the U.N. Human Development Index (HDI), according to a study published online ...

Study finds alarming global rise in use of antibiotics

July 11, 2014
Antibiotic use has surged by 36 percent worldwide in a decade, much of it unwarranted, according to a new study.

Recommended for you

Study: Ibuprofen, acetaminophen more effective than opioids in treating dental pain

April 17, 2018
Opioids are not among the most effective—or longest lasting—options available for relief from acute dental pain, a new examination of the results from more than 460 published studies has found.

Text messaging tool may help fight opioid epidemic

April 17, 2018
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at Washington University School of Medicine and Epharmix, a ...

Marijuana-based drug gets positive review from US agency

April 17, 2018
A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

Post-surgical opioids can, paradoxically, lead to chronic pain

April 16, 2018
Giving opioids to animals to quell pain after surgery prolongs pain for more than three weeks and primes specialized immune cells in the spinal cord to be more reactive to pain, according to a new study by the University ...

Animal study suggests common diabetes drug may also help with nicotine withdrawal

April 5, 2018
In a mouse study, a drug that has helped millions of people around the world manage their diabetes might also help people ready to kick their nicotine habits.

20 years after Viagra, Pfizer seeks another miracle drug

April 1, 2018
It has been 20 years since Viagra was introduced, and Pfizer is still searching for another drug with as much earning power as the revolutionary blue erection pill.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.